These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7576913)

  • 1. Single basic amino acid substitutions at position 302 or 320 in the V3 domain of HIV type 1 are not sufficient to alter the antiviral activity of dextran sulfate and heparin.
    Okada T; Gurney ME
    AIDS Res Hum Retroviruses; 1995 May; 11(5):571-5. PubMed ID: 7576913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of resistance of human immunodeficiency virus type 1 to dextran sulfate associated with the emergence of specific mutations in the envelope gp120 glycoprotein.
    Este JA; Schols D; De Vreese K; Van Laethem K; Vandamme AM; Desmyter J; De Clercq E
    Mol Pharmacol; 1997 Jul; 52(1):98-104. PubMed ID: 9224818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV type 1 infection of CD4+ T cells depends critically on basic amino acid residues in the V3 domain of envelope glycoprotein 120.
    Okada T; Patterson BK; Otto PA; Gurney ME
    AIDS Res Hum Retroviruses; 1994 Jul; 10(7):803-11. PubMed ID: 7986586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of anti-V3 domain antibody binding to human immunodeficiency virus type-1-infected cells by sulfated polysaccharides.
    Okada T; Patterson BK; Gurney ME
    Biochem Biophys Res Commun; 1995 Apr; 209(3):850-8. PubMed ID: 7537501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. V3 loop sequence analysis of seven HIV type 1 group O isolates phenotyped in peripheral blood mononuclear cells and MT-2 cells.
    De Jong J; Simon F; Van der Groen G; Baan E; Saragosti S; Brun-Vézinet F; Goudsmit J
    AIDS Res Hum Retroviruses; 1996 Nov; 12(16):1503-7. PubMed ID: 8911575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain.
    Ivanoff LA; Looney DJ; McDanal C; Morris JF; Wong-Staal F; Langlois AJ; Petteway SR; Matthews TJ
    AIDS Res Hum Retroviruses; 1991 Jul; 7(7):595-603. PubMed ID: 1768461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization.
    De Wolf F; Hogervorst E; Goudsmit J; Fenyö EM; Rübsamen-Waigmann H; Holmes H; Galvao-Castro B; Karita E; Wasi C; Sempala SD
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1387-400. PubMed ID: 7888192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of V2 mutations on escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection of a primary human immunodeficiency virus type 1 isolate.
    Shibata J; Yoshimura K; Honda A; Koito A; Murakami T; Matsushita S
    J Virol; 2007 Apr; 81(8):3757-68. PubMed ID: 17251298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication.
    de Vreese K; Kofler-Mongold V; Leutgeb C; Weber V; Vermeire K; Schacht S; Anné J; de Clercq E; Datema R; Werner G
    J Virol; 1996 Feb; 70(2):689-96. PubMed ID: 8551604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants for the syncytium-inducing phenotype of HIV-1 subtype F isolates are located in the V3 region.
    Holm-Hansen C; Baan E; Asjö B; Pascu FR; Goudsmit J; De Jong JJ
    AIDS Res Hum Retroviruses; 2000 Jun; 16(9):867-70. PubMed ID: 10875612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region.
    Losman B; Bolmstedt A; Schønning K; Björndal A ; Westin C; Fenyö EM; Olofsson S
    AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1067-76. PubMed ID: 11485624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Random copolymers containing specific ratios of negatively charged and aromatic amino acids bind V3 disulfide loop and neutralize diverse HIV type 1 isolates.
    Javaherian K; McDanal C
    AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1163-8. PubMed ID: 8573371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aurothiolates inhibit HIV-1 infectivity by gold(I) ligand exchange with a component of the virion surface.
    Okada T; Patterson BK; Ye SQ; Gurney ME
    Virology; 1993 Feb; 192(2):631-42. PubMed ID: 8421903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the V2, V3, and CD4-binding domains of GP120 in curdlan sulfate neutralization sensitivity of HIV-1 during infection of T lymphocytes.
    Jagodzinski PP; Wustner J; Kmieciak D; Wasik TJ; Fertala A; Sieron AL; Takahashi M; Tsuji T; Mimura T; Fung MS; Gorny MK; Kloczewiak M; Kaneko Y; Kozbor D
    Virology; 1996 Dec; 226(2):217-27. PubMed ID: 8955041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.
    Labrosse B; Treboute C; Brelot A; Alizon M
    J Virol; 2001 Jun; 75(12):5457-64. PubMed ID: 11356952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of HIV type 1 from Romanian children: lack of correlation between V3 loop amino acid sequence and syncytium formation in MT-2 cells.
    Holm-Hansen C; Grothues D; Rustad S; Røsok B; Pascu FR; Asjö B
    AIDS Res Hum Retroviruses; 1995 May; 11(5):597-603. PubMed ID: 7576916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid substitutions in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1.
    Harrowe G; Cheng-Mayer C
    Virology; 1995 Jul; 210(2):490-4. PubMed ID: 7618285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of syncytium-inducing phenotype of HIV type 1 is associated with positively charged residues in the HIV type 1 gp120 V2 domain without fixed positions, elongation, or relocated N-linked glycosylation sites.
    Cornelissen M; Hogervorst E; Zorgdrager F; Hartman S; Goudsmit J
    AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1169-75. PubMed ID: 8573372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.